Rossari BiotechNSE:ROSSARI +0.45%84 Pretax Margin % is 9.38% as of Mar. 2026, which is 4% below its 10-year median of 9.73. GuruFocus rates NSE:ROSSARI with a GF Score™ of 84/100 and a GF Value™ of ₹1,002.43 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,579 Chemicals companies, Rossari Biotech ranks better than 63.08% on this metric.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Rossari Biotech Pretax Margin % Related Terms
Rossari Biotech Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Rossari Biotech's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ROSSARI vs LIN, SHW, ECL: Pretax Margin % Comparison
For the Specialty Chemicals subindustry, Rossari Biotech's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rossari Biotech Pretax Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Rossari Biotech's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Rossari Biotech's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rossari Biotech (NSE:ROSSARI) has a Pretax Margin % of 9.38% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Rossari Biotech and its competitors. This is near median its historical median of 9.73. Over the past decade, Rossari Biotech's Pretax Margin % has ranged from 8.45 to 15.10. According to the industry distribution chart, Rossari Biotech ranks #583 out of 1579 companies in the Chemicals industry, placing it in the top 36.9%.
Is Rossari Biotech's Pretax Margin % too high?
Rossari Biotech's current Pretax Margin % of 9.38% is near median its 10-year median of 9.73. Over the past 10 years, this metric has ranged from a low of 8.45 to a high of 15.10. The Chemicals industry median Pretax Margin % is 5.33. Rossari Biotech's value of 9.38% is 76% above this industry median. Based on the distribution chart, Rossari Biotech ranks #583 out of 1579 companies in the Chemicals industry, which is above the industry midpoint. Overall, Rossari Biotech has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rossari Biotech's Pretax Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Rossari Biotech ranks #583 out of 1579 companies for Pretax Margin %. This puts Rossari Biotech in the upper half of its industry. The industry median Pretax Margin % is 5.33. Rossari Biotech's value of 9.38% is 76% above this benchmark. Historically, Rossari Biotech's own Pretax Margin % has ranged from 8.45 to 15.10 over the past decade. While the company's 10-year median is 9.73 vs. the industry median of 5.33, Rossari Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Chemicals company?
The median Pretax Margin % among Chemicals companies is 5.33, based on 1,579 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rossari Biotech's current Pretax Margin % of 9.38% is 76% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Rossari Biotech and its competitors. For the Chemicals industry, the median Pretax Margin % is 5.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rossari Biotech's current Pretax Margin % is 9.38%, which is near median its own 10-year median of 9.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rossari Biotech stock overvalued right now?
Based on GuruFocus' analysis, Rossari Biotech (NSE:ROSSARI) is currently considered Possible Value Trap. The stock's GF Value™ is ₹1,002.43, compared to a current price of ₹525.35 — trading 47.6% below its estimated fair value. The current Pretax Margin % is 9.38%, which is near median its 10-year median of 9.73 and 76% above the Chemicals industry median of 5.33. Rossari Biotech's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Rossari Biotech (NSE:ROSSARI), the current Pretax Margin % is 9.38% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rossari Biotech (NSE:ROSSARI) Overvalued in 2026?
Based on GuruFocus' analysis, Rossari Biotech stock appears to be undervalued.
The current stock price of ₹525.35 is trading 47.6% below its estimated GF Value™ of ₹1,002.43.
GuruFocus considers Rossari Biotech to be Possible Value Trap.
Key valuation signals for NSE:ROSSARI:
Pretax Margin %: 9.38% (near median its 10-year median of 9.73)
GF Value™: ₹1,002.43 vs. price of ₹525.35 (47.6% below fair value)
Industry Position: 76% above the Chemicals median (#583 of 1579)
No single metric tells the full story. See the NSE:ROSSARI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rossari Biotech Ltd is a specialty chemical manufacturing company. It provides customized solutions to specific industrial and production requirements of its customers in the FMCG, apparel, poultry, and animal feed industries through its product portfolio comprising home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its business is organized into three categories: home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its products include soaps and detergents, paints, inks and coatings, ceramics and tiles, water treatment chemicals, pulp and paper, and cleaning chemical formulations, among others. The company generates the majority revenue from India.
84GF Score
Get the complete analysis for NSE:ROSSARI
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ROSSARI has been successfully added to your 
